SCOR initiates criminal actions against Thierry Derez and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
32
SCOR initiates criminal actions against Thierry Derez and Covéa for breach of trust and concealment of breach of trust

Press Release January 29, 2019 - N° 3

SCOR initiates criminal actions against  Thierry Derez and Covéa for breach of trust and concealment of breach of trust

SCOR just learned with great surprise and astonishment that, during market operating hours, Covéa issued a press release stating that "a transaction with SCOR is no longer part of its strategic options". SCOR has decided to bring this matter to the attention of the Autorité des Marchés Financiers (AMF).

SCOR had not previously been informed of Covéa's change of position. SCOR strongly denies the claim by Covéa that there were "continued attacks and hostile tactics targeting Covéa". In particular, SCOR has made no public statement on Covéa and its intentions since November 13 th 2018.

SCOR has had serious doubts since last August about the intentions and behavior of Thierry Derez and Covéa. These doubts are now substantiated.

Given the seriousness of the facts and evidence brought to the attention of SCOR and its governance bodies relating to the misconduct committed to the detriment of SCOR, in the context of the preparation and submission by Covéa of its unsolicited proposed combination with the SCOR group, SCOR has been compelled to initiate legal actions against Thierry Derez (Chairman and Chief Executive Officer of Covéa SGAM, Chairman of Covéa Coopérations and former director of SCOR in his personal capacity), Covéa SGAM and Covéa Coopérations as legal entities [1] , Barclays (Covéa's financial advisor and financing bank) and Rothschild. These legal actions consist of:

  • a criminal action, by way of a direct prosecution (" citation directe ") before the Criminal Court of Paris (" Tribunal correctionnel de Paris "), against Thierry Derez, for breach of trust (" abus de confiance ");
  • a criminal action, by way of a direct prosecution (" citation directe ") before the Criminal Court of Paris (" Tribunal correctionnel de Paris "), against Covéa, for concealment of breach of trust (" recel d'abus de confiance "); and
  • a civil action against Rothschild in France and against Barclays before the High Court of Justice of London, for serious breach of confidence and trade secrets.

SCOR also intends to initiate the following legal actions against Thierry Derez and Covéa:

  • a civil action (" action en responsabilité civile "), before the Commercial Court of Paris (" Tribunal de commerce de Paris "), against Thierry Derez, for serious breach of his legal and fiduciary duties and obligations as a director of SCOR in his personal capacity (regarding in particular loyalty, conflicts of interest, and confidentiality) as well as SCOR's trade secrets (" secret des affaires "); and
  •  a civil action (" action en responsabilité civile "), before the Commercial Court of Paris (" Tribunal de commerce de Paris "), against Covéa, for having directly participated in and benefitted from the serious breaches by Thierry Derez.

These proceedings are intended to sanction and remedy the alleged criminal and civil misconduct having resulted from, inter alia , the unlawful misappropriation, disclosure, communication and use of SCOR's sensitive and strictly confidential documents and information which Thierry Derez had access to as a director of SCOR in his personal capacity. The SCOR group considers in particular that this unacceptable misconduct was committed with the aim of wrongfully favoring the preparation and submission by Covéa of its unsolicited proposed combination with SCOR. This serious misconduct has compelled SCOR to bring actions before the relevant courts.

SCOR was informed by Credit Suisse in November 2018 of its decision, for reasons of compliance with the laws and regulations in force, to withdraw its support for any plans by Covéa to take control of SCOR. SCOR commends this decision by Crédit Suisse, which is to its credit.

SCOR intends to inform the relevant regulatory authorities in France and abroad of these legal actions.

SCOR points out that:

  • during its meeting held on August 30, 2018, its Board of Directors unanimously decided to refuse to initiate discussions with Covéa regarding its unsolicited proposed combination with SCOR, which had been submitted to SCOR on August 24, 2018, i.e ., more than seven months prior to the expiry of the standstill undertaking entered into, and published on April 11, 2016, by Covéa not to increase its shareholding in SCOR in excess of 10% of the share capital. SCOR's Board of Directors reviewed the terms and conditions of this unsolicited proposal in detail and determined that it was fundamentally incompatible with SCOR's strategy of independence, which is a key factor of its development, that it would jeopardize its strong value-creating strategy and that it reflected neither the intrinsic value nor the strategic value of SCOR. As a result, given, inter alia , its detrimental consequences for the Group, its shareholders and its employees, SCOR indicated in its press release dated September 4, 2018 that any public bid by Covéa would be deemed hostile; [2]
  • during its meeting held on September 21, 2018, following in particular Covéa's renewed expressions of interest in an allegedly "friendly" combination with SCOR despite the fact that SCOR's Board of Directors had already unanimously rejected Covéa's unsolicited proposal on August 30, 2018, SCOR's Board of Directors decided, unanimously, to reaffirm in all respects its refusal to enter into discussions with Covéa and to note that the procedure and methods used by Thierry Derez and Covéa to prepare, submit and make public this proposed combination, as well as their renewed expressions of interest, can only be considered as hostile and unfriendly and disrupted the functioning of the Company; [3]
  • and following multiple reminders by SCOR to Thierry Derez regarding his obvious situation of conflict of interests due to Covéa's unsolicited proposed combination and the opinion rendered on October 30, 2018 by the Haut Comité de Gouvernement d'Entreprise consulted by SCOR regarding the situation of Thierry Derez, the latter was finally compelled to resign from SCOR's Board of Directors on November 13, 2018 [4]

The SCOR group strongly condemns the serious misconduct committed by Thierry Derez and by Covéa. It remains fully committed to defending its rights.

This publication is an ad hoc disclosure pursuant to Article 17 of Regulation (EU) No 596/2014 of 16 April 2014.

*

*         *

Contact details

Marie-Laurence Bouchon Group Head of Communications +33 (0)1 58 44 75 43 mbouchon@scor.com

Ian Kelly Head of Investor Relations +44 (0)203 207 8561 ikelly@scor.com

http://www.scor.com/

Twitter: @SCOR_SE

Forward-looking statements

SCOR does not communicate "profit forecasts" in the sense of Article 2 of (EC) Regulation n°809/2004 of the European Commission. Thus, any forward-looking statements contained in this communication should not be held as corresponding to such profit forecasts. Information in this communication may include "forward-looking statements", including but not limited to statements that are predictions of or indicate future events, trends, plans or objectives, based on certain assumptions and include any statement which does not directly relate to a historical fact or current fact. Forward-looking statements are typically identified by words or phrases such as, without limitation, "anticipate", "assume", "believe", "continue", "estimate", "expect", "foresee", "intend", "may increase" and "may fluctuate" and similar expressions or by future or conditional verbs such as, without limitations, "will", "should", "would" and "could." Undue reliance should not be placed on such statements, because, by their nature, they are subject to known and unknown risks, uncertainties and other factors, which may cause actual results, on the one hand, to differ from any results expressed or implied by the present communication, on the other hand.

Please refer to the 2017 reference document filed on February 23, 2018, under number D.18-0072 with the French Autorité des marchés financiers (AMF) posted on SCOR's website www.scor.com (the "Document de Référence"), for a description of certain important factors, risks and uncertainties that may affect the business of the SCOR Group. As a result of the extreme and unprecedented volatility and disruption of the current global financial crisis, SCOR is exposed to significant financial, capital market and other risks, including movements in interest rates, credit spreads, equity prices, and currency movements, changes in rating agency policies or practices, and the lowering or loss of financial strength or other ratings.

The Group's financial information is prepared on the basis of IFRS and interpretations issued and approved by the European Union. This financial information does not constitute a set of financial statements for an interim period as defined by IAS 34 "Interim Financial Reporting".

[1] Referred to together as "Covéa" in this press release.

[2] Please refer to SCOR's press release dated September 4, 2018 " SCOR Reaffirms its Independence and Acknowledges Covéa's Decision to Withdraw its Proposal on a Potential Combination. "

[3] Please refer to SCOR's press release dated September 27, 2018.

[4] Please refer to SCOR's press release dated November 13, 2018 " SCOR Acknowledges Thierry Derez's Decision to Resign from his Position as a Member of SCOR's Board of Directors, Following the Opinion Rendered by the Haut Comité de Gouvernement d'Entreprise ."

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 545

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 791

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 129

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 188

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 190

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 138

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 40

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Volvo Ends LiDAR Partnership: What This Means for LAZR Stock

Updated Category News Views 315

Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...

Continue Reading
Samsung and Xiaomi Face Antitrust Findings in India Market

Updated Category News Views 157

Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...

Continue Reading
Bonnie Navin Honored as Top 25 Medical Malpractice Attorney

Updated Category News Views 164

Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...

Continue Reading
Top Dividend Stocks for Long-Term Passive Income Investors

Updated Category News Views 99

Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...

Continue Reading
Cathie Wood Predicts Deflationary Boom Amid Market Decline

Updated Category News Views 404

Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...

Continue Reading